Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126845031 | 12684503 | 1 | I | 201503 | 20150701 | 20160825 | 20160825 | EXP | US-BAYER-2015-374615 | BAYER | 56.00 | YR | A | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126845031 | 12684503 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, UNK | U | 0 | 20 | MG | FILM-COATED TABLET | ||||||
| 126845031 | 12684503 | 2 | SS | XARELTO | RIVAROXABAN | 1 | U | 0 | FILM-COATED TABLET | ||||||||||
| 126845031 | 12684503 | 3 | SS | XARELTO | RIVAROXABAN | 1 | U | 0 | FILM-COATED TABLET | ||||||||||
| 126845031 | 12684503 | 4 | SS | XARELTO | RIVAROXABAN | 1 | U | 0 | FILM-COATED TABLET | ||||||||||
| 126845031 | 12684503 | 5 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Unknown | UNK | U | 999999 | |||||||||
| 126845031 | 12684503 | 6 | SS | HEPARIN | HEPARIN SODIUM | 1 | Unknown | UNK | 0 | ||||||||||
| 126845031 | 12684503 | 7 | SS | APIXABAN | APIXABAN | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 126845031 | 12684503 | 8 | C | CHOLESTEROL | CHOLESTEROL | 1 | Unknown | UNK | 0 | ||||||||||
| 126845031 | 12684503 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK | 0 | ||||||||||
| 126845031 | 12684503 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126845031 | 12684503 | 11 | C | XANAX | ALPRAZOLAM | 1 | Unknown | UNK | 0 | ||||||||||
| 126845031 | 12684503 | 12 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126845031 | 12684503 | 1 | Embolism |
| 126845031 | 12684503 | 2 | Cerebrovascular accident prophylaxis |
| 126845031 | 12684503 | 3 | Atrial fibrillation |
| 126845031 | 12684503 | 4 | Embolism venous |
| 126845031 | 12684503 | 5 | Product used for unknown indication |
| 126845031 | 12684503 | 6 | Product used for unknown indication |
| 126845031 | 12684503 | 7 | Atrial fibrillation |
| 126845031 | 12684503 | 9 | Blood pressure measurement |
| 126845031 | 12684503 | 10 | Thyroid disorder |
| 126845031 | 12684503 | 11 | Anxiety |
| 126845031 | 12684503 | 12 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126845031 | 12684503 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126845031 | 12684503 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126845031 | 12684503 | 1 | 20140320 | 20140419 | 0 | |
| 126845031 | 12684503 | 9 | 2006 | 0 |